Essentials of Oncothermia

Table 5

Summary of the studies made by oncothermia treatment. (end points are quality of life connected.)

Study	Number of patients	Pain reduction [%]	Increasing performances [%]	Better overall QoL [%]	Reference
Colorectal inoperable, liver metastasis	60
CDDP	28	17.86	39.29	57.14	[108]
OXALI	32	46.88	7.86	100.00
Borreliosis	12		100.00	100.00	[117]
Abdominal effusion + oncothermia	49	88.88	73.91	85.70	[110]
Colon cancer study, phase II, prospective, three arms, randomized	154				[110]
Clifford TCM	53	37.7	13.73	58.49
Monotherapy	50	36	23.53	60
Combined therapy	51	58.8	62.75	86.28
Prostate study	184				[113]
Prostate study	115		76.2	94.1	[118]
Colon operability	7		86	43	[112]
CRC liver	15				[75]
CRC liver oxaliplatin	12	66.7		83.3	[77]
CRC liver cisplatin	18	11.1		27.8